NASDAQ:ISLEU

Isleworth Healthcare Acquisition Stock Forecast, Price & News

$9.90
-0.03 (-0.30 %)
(As of 03/29/2021)
Add
Compare
Today's Range
$9.84
Now: $9.90
$9.90
50-Day Range
$9.81
MA: $9.96
$10.10
52-Week Range
$9.81
Now: $9.90
$10.18
Volume2,388 shs
Average Volume265,077 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
There is no company description available for Isleworth Healthcare Acquisition Corp.

Industry, Sector and Symbol

Industry --
Sub-IndustryN/A
Sector--
Current SymbolNASDAQ:ISLEU
CUSIPN/A
CIKN/A
WebN/A
PhoneN/A
EmployeesN/A
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Next Earnings DateN/A
OptionableNot Optionable

MarketRank

Overall MarketRank

0.00 out of 5 stars

-- Sector

252nd out of 266 stocks

-- Industry

254th out of 268 stocks

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
$9.90
-0.03 (-0.30 %)
(As of 03/29/2021)
30 days | 90 days | 365 days | Advanced Chart

Receive ISLEU News and Ratings via Email

Sign-up to receive the latest news and ratings for ISLEU and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Isleworth Healthcare Acquisition (NASDAQ:ISLEU) Frequently Asked Questions

What stocks does MarketBeat like better than Isleworth Healthcare Acquisition?

Wall Street analysts have given Isleworth Healthcare Acquisition a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Isleworth Healthcare Acquisition wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are some of Isleworth Healthcare Acquisition's key competitors?

What is Isleworth Healthcare Acquisition's stock symbol?

Isleworth Healthcare Acquisition trades on the NASDAQ under the ticker symbol "ISLEU."

When does the company's lock-up period expire?

Isleworth Healthcare Acquisition's lock-up period expires on Tuesday, August 24th. Isleworth Healthcare Acquisition had issued 18,000,000 shares in its initial public offering on February 25th. The total size of the offering was $180,000,000 based on an initial share price of $10.00. Shares of the company owned by major shareholders and company insiders will be eligible for trade following the end of the lock-up period.

How do I buy shares of Isleworth Healthcare Acquisition?

Shares of ISLEU can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Isleworth Healthcare Acquisition's stock price today?

One share of ISLEU stock can currently be purchased for approximately $9.90.


This page was last updated on 4/13/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.